Advize Health
  • About Us
  • Solutions
    • For Payers
    • For Legal
    • For Doctors & Hospitals
    • For Federal
    • Risk Adjustment Integrity Group
  • Resources
    • Case Studies
    • Blog
  • Contact
Select Page
Big Pharma Went All In to Kill Drug Pricing Negotiations

Big Pharma Went All In to Kill Drug Pricing Negotiations

by Advize Admin | Aug 12, 2022 | Business, Healthcare

For decades, the drug industry has yelled bloody murder each time Congress considered a regulatory measure that threatened its profits. But the hyperbole reached a new pitch in recent weeks as the Senate moved to adopt modest drug pricing negotiation measures in the...

Podcast: What the Health?: Dealing With Drug Prices

by Erik Consorsha | Jan 14, 2022 | Healthcare

Click here for a transcript of the episode. In this episode of What the Health: Medicare officials have preliminarily decided to restrict reimbursement for Aduhelm, the controversial Alzheimer’s drug, to only patients participating in the approved clinical trials. The...

Recent Posts

  • Nursing Home Owners Drained Cash During Pandemic While Residents Deteriorated
  • FDA Experts Are Still Puzzled Over Who Should Get Which Covid Shots and When
  • Did Your Health Plan Rip Off Medicare?
  • Meet Justine.
  • Money Isn’t Everything but the Audits and Investigations are Free

Recent Comments

    Advize Health, LLC products and services are in compliance with Section 508 Standards. Section 508 of the Rehabilitation Act, as amended by the Workforce Investment Act of 1998 (P.L. 105-220) and Section 508 accessibility standards at 36 CFR 1194.

    © 2022 Advize Health LLC